阿奇霉素联合痰热清治疗小儿肺炎支原体肺炎疗效.pdf

《阿奇霉素联合痰热清治疗小儿肺炎支原体肺炎疗效.pdf》由会员上传分享，免费在线阅读，更多相关内容在应用文档-天天文库。

1、·514·世界中西医结合杂志2014年第9卷第5期WorldJournalofIntegratedTraditionalandWesternMedicine2014，Vo1．9，No．5·临床研究·阿奇霉素联合痰热清治疗小儿肺炎支原体肺炎疗效胡晓静【摘要】目的观察阿奇霉素联合痰热清治疗小儿肺炎支原体肺炎的临床疗效。方法将90例确诊为肺炎支原体肺炎的患儿随机分为治疗组45例和对照组45例。对照组单用阿奇霉素序贯治疗，治疗组在阿奇霉素序贯治疗的基础上联合痰热清治疗。观察两组的退热时间、咳嗽消失时间、肺部哕音消失

2、时间及胸片吸收好转时间等临床疗效。结果治疗组总有效率97．8％，对照组总有效率80．0％，两组差异有统计学意义(P<0．05)。治疗组的退热时间、咳嗽消失时间、肺部哕音消失时间及胸片吸收好转时间均明显短于对照组(P<0．05)。结论阿奇霉素联合痰热清治疗小儿肺炎支原体肺炎疗效好，治疗时间短，安全可靠，值得临床推广。【关键词】支原体肺炎；儿童；痰热清注射液；阿奇霉素；中西医治疗【中图分类号】R725．6【文献标识码】A【文章编号】1673—6613(2014)05—0514—03EficacyonMycopl

3、asmaPneumomaTreatedwithAzithromycinandTan．reqingInjectioninChildrenHUXiao—jing(GansuLanzhouSecondPeopleSHospital，LanzhouGansu730046)【Abstract】0bjectiveToobservetheclinicalefficacyonmycoplasmapneumoniatreatedwithAz—ithromyeinandTanreqingInjectioninchildren．

4、MethodsNinetycasesofmycoplasmapneumoniawereran—domizedintoatreatmentgroup(45cases)andacontrolgroup(45cases)。Inthecontrolgroup，Azithromycinsequentialtherapywasappliedsimply．Inthetreatmentgroup，onthebasisofAzithromycinsequentialthera—PY，TanreqingInjectionwas

5、combined．Theclinicalefficacywasobservedinthetwogroupsintermsofantife—briletime，timeofcoughreliefandralesdisappearanceaswellastheabsorptionimprovements．ResultsThetotaleffectiveratewas97．8％inthetreatmentgroupandwas80．0％inthecontrolgroup．indicatingthesig—nifi

6、cantdifference(P<0．05)．Theantifebriletime，timeofcoughreliefandralesdisappearanceaswellastheabsorptionimprovementswereshorterapparentlyinthetreatmentthanthoseinthecontrolgroup(P<0．05)．ConclusionAzithromycinandTanreqingInjectionincombinationachievetheeffecti

7、veresultsinthetreatmentofchildrenmycoplasmapneumonia，characterizedasshortdurationoftreatmentandreliablesafety．Hence，thistherapydeservestobepromotedclinically．【Keywords】MycoplasmaPneumonia；Children；TanreqingInjection；Azithromycin；IntegratedChi—neseandWester

8、nMedicineTherapy肺炎支原体肺炎是由肺炎支原体感染引起的近年来儿童支原体肺炎发病率呈上升趋势，且发病急性呼吸系统感染性疾病，主要通过呼吸道飞沫传年龄逐渐趋小。随着肺炎支原体肺炎肺外损害的播，全年均有发病，以冬季较多。儿童由于其呼吸增多，难治性肺炎支原体肺炎病例越来越多，甚至系统解剖生理特点以及免疫系统尚未发育完善，对可危及生命。支原体肺炎在临床治疗上多应用病原体的抵抗力相对较差，故感染后容易导致肺大